ALEXION PHARMACEUTICALS, INC.: key financial figures for fiscal year 2020 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2020)
- $6.1B
- Net Income/Loss (FY2020)
- $603.4M
- Total Assets (FY2020)
- $18.1B
- Total Equity (FY2020)
- $11.7B
- Cash Flows from Operating Activities (FY2020)
- $3.0B
Source: ALEXION PHARMACEUTICALS, INC. 10-K filing (FY2020). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
